February 2022

Six weeks of 10-minute sessions using a smartphone app reduced depressive symptoms in patients with diabetes or hypertension in Brazil and Peru, according to 2 recent randomized clinical trials.
Read More

A comparative effectiveness study of real-world data from patients with multiple sclerosis showed that dimethyl fumarate and fingolimod were equivalent and rituximab was superior to natalizumab for reducing relapse.
Read More

Migraines may be classified into 3 subtypes based on headache intensity, frequency, and the presence of photophobia and phonophobia, according to a new analysis.
Read More

For seizures that occur during sleep, deeper sleep in the 5 minutes preceding a seizure was correlated with a reduced heart rate after the seizure, according to a recent study.
Read More

Discontinuation of pimavanserin for dementia-related psychosis was associated with a higher rate of relapse compared with continuation, according to a recent randomized discontinuation trial that was stopped early for efficacy.
Read More

Subscribe to
Value-Based Care in Neurology

Stay up to date with personalized medicine by subscribing to receive the free VBCN e‑Newsletter.

I'd like to receive: